中华心血管病杂志
中華心血管病雜誌
중화심혈관병잡지
Chinese Journal of Cardiology
2015年
10期
854-857
,共4页
郭曦%李彭%刘光锐%黄小勇%勇强%王国勤%黄连军
郭晞%李彭%劉光銳%黃小勇%勇彊%王國勤%黃連軍
곽희%리팽%류광예%황소용%용강%왕국근%황련군
血流储备分数,心肌%主动脉疾病%肾循环
血流儲備分數,心肌%主動脈疾病%腎循環
혈류저비분수,심기%주동맥질병%신순배
Fractional flow reserve,myocardial%Aortic diseases%Renal circulation
目的 探讨血流储备分数(FFR)在主动脉夹层累及肾动脉患者介入治疗中的应用价值.方法 回顾性分析2013年5月至2014年2月在北京安贞医院治疗的12例Stanford B型主动脉夹层导致单侧肾动脉受累缺血患者的临床资料.主动脉造影显示肾动脉受累的患者在进行肾动脉FFR检查后,行胸主动脉腔内修复术.术后再次行肾动脉FFR检查,FFR>0.90的患者终止手术;FFR≤0.90或肾动脉狭窄近端与远端的平均压压差>20 mmHg(1 mmHg =0.133 kPa)的患者则进行肾动脉支架置入术.术后1个月检查肾功能;术后1和3个月行超声造影检查.结果 胸主动脉腔内修复术前,1例患者的受累肾动脉FFR值为0.90,其余11例患者的受累肾动脉FFR<0.90.术后即刻血管造影,示8例患者的两侧肾动脉血流畅通,FFR>0.90;4例患者的受累肾动脉FFR<0.90,完成肾动脉支架置入术后FFR>0.90.术后1个月,血尿素[(8.84±3.99) mmol/L比(5.18±1.69)mmol/L,P=0.011]和尿酸[(359.3±77.3) μmol/L比(276.9±108.3) μmol/L,P=0.008]均较术前降低,血肌酐手术前后差异无统计学意义(P =0.760).术后1和3个月,超声造影示患者肾动脉血流均通畅.结论 对肾动脉受累的Stanford B型主动脉夹层患者进行FFR检查,可数据化评估靶器官的血流灌注,并指导介入治疗.
目的 探討血流儲備分數(FFR)在主動脈夾層纍及腎動脈患者介入治療中的應用價值.方法 迴顧性分析2013年5月至2014年2月在北京安貞醫院治療的12例Stanford B型主動脈夾層導緻單側腎動脈受纍缺血患者的臨床資料.主動脈造影顯示腎動脈受纍的患者在進行腎動脈FFR檢查後,行胸主動脈腔內脩複術.術後再次行腎動脈FFR檢查,FFR>0.90的患者終止手術;FFR≤0.90或腎動脈狹窄近耑與遠耑的平均壓壓差>20 mmHg(1 mmHg =0.133 kPa)的患者則進行腎動脈支架置入術.術後1箇月檢查腎功能;術後1和3箇月行超聲造影檢查.結果 胸主動脈腔內脩複術前,1例患者的受纍腎動脈FFR值為0.90,其餘11例患者的受纍腎動脈FFR<0.90.術後即刻血管造影,示8例患者的兩側腎動脈血流暢通,FFR>0.90;4例患者的受纍腎動脈FFR<0.90,完成腎動脈支架置入術後FFR>0.90.術後1箇月,血尿素[(8.84±3.99) mmol/L比(5.18±1.69)mmol/L,P=0.011]和尿痠[(359.3±77.3) μmol/L比(276.9±108.3) μmol/L,P=0.008]均較術前降低,血肌酐手術前後差異無統計學意義(P =0.760).術後1和3箇月,超聲造影示患者腎動脈血流均通暢.結論 對腎動脈受纍的Stanford B型主動脈夾層患者進行FFR檢查,可數據化評估靶器官的血流灌註,併指導介入治療.
목적 탐토혈류저비분수(FFR)재주동맥협층루급신동맥환자개입치료중적응용개치.방법 회고성분석2013년5월지2014년2월재북경안정의원치료적12례Stanford B형주동맥협층도치단측신동맥수루결혈환자적림상자료.주동맥조영현시신동맥수루적환자재진행신동맥FFR검사후,행흉주동맥강내수복술.술후재차행신동맥FFR검사,FFR>0.90적환자종지수술;FFR≤0.90혹신동맥협착근단여원단적평균압압차>20 mmHg(1 mmHg =0.133 kPa)적환자칙진행신동맥지가치입술.술후1개월검사신공능;술후1화3개월행초성조영검사.결과 흉주동맥강내수복술전,1례환자적수루신동맥FFR치위0.90,기여11례환자적수루신동맥FFR<0.90.술후즉각혈관조영,시8례환자적량측신동맥혈류창통,FFR>0.90;4례환자적수루신동맥FFR<0.90,완성신동맥지가치입술후FFR>0.90.술후1개월,혈뇨소[(8.84±3.99) mmol/L비(5.18±1.69)mmol/L,P=0.011]화뇨산[(359.3±77.3) μmol/L비(276.9±108.3) μmol/L,P=0.008]균교술전강저,혈기항수술전후차이무통계학의의(P =0.760).술후1화3개월,초성조영시환자신동맥혈류균통창.결론 대신동맥수루적Stanford B형주동맥협층환자진행FFR검사,가수거화평고파기관적혈류관주,병지도개입치료.
Objective To analyze the value of fractional flow reserve (FFR) measurement on endovascular therapy for patients with renal artery stenosis.Methods Clinical data of 12 patients with Stanford B type aortic dissection complicated with renal blood flow injury in Anzhen hospital hospitalized from May 2013 to February 2014 were retrospectively analyzed.Renal artery angiography was performed and fractional flow reserve (FFR) was measured before Thoracic endovascular aortic repair.After operation, renal artery FFR was measured again, and renal artery stenting was performed in patients with FFR≤0.90 or average pressure difference between proximal and distal of renal artery > 20 mmHg(1 mmHg =0.133 kPa) and not applied for patients with FFR > 0.90.The patients were then subsequently followed up clinically.Kidney function were measured after 1 month, and contrast-enhanced ultrasonography data were obtained at 1 and 3 months later, respectively.Results The FFR of 1 patient was 0.90, while the FFR of other patients were less than 0.90 before thoracic endovascular aortic repair.After the procedure, the angiography showed that the blood flow of renal artery in 8 patients were fluency, and the FFR index was over 0.90.There were 4 patients with FFR less than 0.90.After renal artery stenting, the FFR of these 4 patients were all above 0.90.Compared with pre-procedure, blood urea nitrogen ((8.84 ± 3.99) mmol/L vs.(5.18 ± 1.69) mmol/L, P =0.011) and uric acid ((359.3 ± 77.3) μmol/L vs.(276.9 ± 108.3) μmol/L, P =0.008) decreased significantly after 1 month, and there was no significant difference in serum creatinine (P =0.760).Contrast-enhanced ultrasonography results showed that blood flow of renal artery were fluency after 1 month and 3 months.Conclusion In patients with aortic dissection complicating renal blood flow injury, the FFR measurement is meaningful in evaluating the blood flow status of target organs and guide the endovascular revascularization